| Travere Therapeutics, Inc. | 145K | US$8.54M | 7.1% |
| Cytokinetics, Incorporated | 128K | US$8.44M | 7.0% |
| BridgeBio Pharma, Inc. | 100K | US$6.58M | 5.4% |
| ACADIA Pharmaceuticals Inc. | 320K | US$6.45M | 5.3% |
| Tarsus Pharmaceuticals, Inc. | 70,000 | US$5.5M | 4.5% |
| PTC Therapeutics, Inc. | 80,000 | US$5.18M | 4.3% |
| Praxis Precision Medicines, Inc. | 17,000 | US$4.95M | 4.1% |
| Vera Therapeutics, Inc. | 150K | US$4.84M | 4.0% |
| Arcutis Biotherapeutics, Inc. | 180K | US$4.76M | 3.9% |
| Annexon, Inc. | 1.12M | US$4.74M | 3.9% |
| United Therapeutics Corporation | 8,000 | US$4.34M | 3.6% |
| Xeris Biopharma Holdings, Inc. | 400K | US$3.82M | 3.2% |
| Celcuity Inc. | 48,000 | US$3.82M | 3.2% |
| DBV Technologies SA | 270K | US$3.18M | 2.6% |
| Viridian Therapeutics, Inc. | 150K | US$3.09M | 2.6% |
| Zentalis Pharmaceuticals, Inc. | 1.08M | US$2.99M | 2.5% |
| BioMarin Pharmaceutical Inc. | 48,000 | US$2.88M | 2.4% |
| Biogen Inc. | 12,000 | US$2.71M | 2.2% |
| Mineralys Therapeutics, Inc. | 100K | US$2.51M | 2.1% |
| Ligand Pharmaceuticals Incorporated | 8,000 | US$2.5M | 2.1% |
| Ultragenyx Pharmaceutical Inc. | 160K | US$2.4M | 2.0% |
| Vaxcyte, Inc. | 40,000 | US$2.28M | 1.9% |
| ORIC Pharmaceuticals, Inc. | 160K | US$2.16M | 1.8% |
| Axsome Therapeutics, Inc. | 10,000 | US$1.84M | 1.5% |
| Silence Therapeutics PLC | 160K | US$1.75M | 1.4% |
| Beam Therapeutics Inc. | 70,000 | US$1.71M | 1.4% |
| Biohaven Ltd. | 120K | US$1.6M | 1.3% |
| Contineum Therapeutics, Inc. | 108K | US$1.45M | 1.2% |
| Genmab A/S | 40,000 | US$1.43M | 1.2% |
| Neurocrine Biosciences, Inc. | 8,000 | US$1.13M | 0.94% |
| Monopar Therapeutics Inc. | 12,000 | US$956K | 0.79% |
| ARS Pharmaceuticals, Inc. | 200K | US$862K | 0.71% |
| Ionis Pharmaceuticals, Inc. | 16,000 | US$714K | 0.59% |
| Olema Pharmaceuticals, Inc. | 80,000 | US$691K | 0.57% |
| Lexicon Pharmaceuticals, Inc. | 320K | US$600K | 0.50% |
| Savara, Inc. | 80,000 | US$413K | 0.34% |
| Erasca, Inc. | 0 | US$0 | 0.00% |
| Gossamer Bio, Inc. | 0 | US$0 | 0.00% |
| Insmed Incorporated | 0 | US$0 | 0.00% |
| Kura Oncology, Inc. | 0 | US$0 | 0.00% |
| Nektar Therapeutics | 0 | US$0 | 0.00% |
| Nuvation Bio Inc. | 0 | US$0 | 0.00% |
| Scholar Rock Holding Corporation | 0 | US$0 | 0.00% |
| Sionna Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tonix Pharmaceuticals Holding Corp. | 0 | US$0 | 0.00% |
| Vertex Pharmaceuticals Incorporated | 0 | US$0 | 0.00% |
| Agios Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Alnylam Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Crinetics Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Enliven Therapeutics, Inc. | 0 | US$0 | 0.00% |